Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Has Been Filed Against CareFusion Corporation Relating to Its Acquisition by Becton Dickinson -- CFN


NEW YORK, Oct. 10, 2014 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been commenced in the Delaware Court of Chancery on behalf of owners of CareFusion Corporation ("CareFusion" or the "Company") (NYSE:CFN) seeking to challenge the Company's recently announced merger.

On October 5, 2014, CareFusion and Becton Dickinson & Company ("Becton") announced the signing of a definitive merger agreement pursuant to which Becton will acquire CareFusion in a merger worth $12.2 billion. As a result of the merger, CareFusion shareholders are only anticipated to receive a total of $58.00 per share ($49.00 per share in cash and 0.0777 of a share of Becton) in exchange for each share of CareFusion.

If you purchased CareFusion common stock prior to the October 5th announcement and still own these shares, we urge you to contact Wolf Haldenstein immediately so that we can discuss the case and your rights in the matter.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has over 70 attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com. All e-mail correspondence should make reference to the "CareFusion investigation."

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.



            

Contact Data